<DOC>
	<DOCNO>NCT02679885</DOCNO>
	<brief_summary>It known teriflunomide , treatment relapse form multiple sclerosis , find low concentration semen . Because drug associate teratogenicity laboratory animal , question raise whether drug detect female partner sexually active male take drug treat multiple sclerosis .</brief_summary>
	<brief_title>Teriflunomide Male Transmission Study</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>1 . Males relapse form multiple sclerosis appropriately treat teriflunomide 14 mg po daily ; 2 . Continuous treatment three month good compliance assess investigator 3 . Age 18 55 4 . Penilevaginal intercourse female partner least twice month unimpeded ejaculation . 5 . Compliance safety assessment , e.g. , regular bloodwork complete blood count liver function test recommended Package Insert 6 . Able give inform consent Females 1 . Regular sexual intercourse male partner actively take teriflunomide 2 . Age 18 55 3 . Able give inform consent 4 . Negative urine pregnancy test time blood sample 5 . Reliable contraception involve barrier method 1 . Use barrier method contraception 2 . For male , contraindication continue use teriflunomide 3 . Couples actively try conceive 4 . For male , noncompliance teriflunomide therapy 5 . Inability unwilling give consent comply protocol 6 . Pregnancy female sexual partner .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>